Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2025.Jul.31

Announcement for the expected date of the Board of Directors Meeting for 2025Q2 consolidated financial report is 2025/08/11

2025.Jul.28

Announcement on behalf of OBIGEN Pharma of the BOD’s resolution to lift the non-competition restrictions for CEO

2025.Jul.18

OBI-902 TROP2 ADC has been granted by the TFDA to proceed to Phase I/II human clinical trial

2025.Jun.27

Announcement of 1st Sustainable Development Committee Members

2025.Jun.27

Announcement of 6th Remuneration and Nomination Committee Members

2025.Jun.27

The Company’s Board of Directors nominated Dr. Kung-Yee Liang to serve as the Chairperson of the Board

2025.Jun.27

Announcement of 5th Audit and Risk Management Committee Members

2025.Jun.27

Announcement of 2025 Annual General Shareholders' meeting’s resolution to lift the non-competition restrictions for directors

2025.Jun.27

Announcement of Re-election of directors at the 2025 annual shareholders’ meeting

2025.Jun.27

Announcement of the Company’s important resolutions of the 2025 Annual General Shareholders’ meeting.

News

Latest News

Events

Latest events